01177 中国生物制药
按盘价 
2.770 +0.030 (+1.095%) | 2023/06 - 中期 人民币(千) | 2022/06 人民币(千) | 2021/06 人民币(千) | 2020/06 人民币(千) | 2019/06 人民币(千) |
非流动资产
| 投资物业 | 713,651 | 733,218 | 293,933 | 560,915 | 356,453 |
| 物业、厂房、设备及其他 | 7,897,904 | 7,394,940 | 7,078,474 | 7,244,380 | 6,069,779 |
| 租賃土地 | 1,686,344 | 1,377,536 | 1,648,191 | -- | 1,294,674 |
| 无形资产 | 2,941,691 | 1,856,621 | 1,821,774 | 21,332,960 | 21,942,838 |
| 联营公司及共同控制公司权益 | 13,083,084 | 14,814,226 | 11,218,558 | 946,145 | 331,760 |
| 其他非流动资产 | 12,340,944 | 13,560,158 | 10,332,481 | 3,862,852 | 1,610,512 |
| 38,663,618 | 39,736,699 | 32,393,411 | 33,947,252 | 31,606,016 |
流动资产
| 存货 | 2,018,498 | 2,137,132 | 1,731,596 | 1,802,666 | 1,519,652 |
| 现金及银行结存 | 11,577,189 | 7,768,292 | 8,028,326 | 17,090,761 | 7,181,548 |
| 其他流动资产 | 13,381,582 | 15,292,337 | 14,053,396 | 15,507,661 | 13,163,971 |
| 持作出售资产 | 0 | 0 | 0 | 0 | 0 |
| 26,977,269 | 25,197,761 | 23,813,318 | 34,401,088 | 21,865,171 |
流动负债
| 其他流动负债 | 26,865,415 | 16,265,507 | 11,485,492 | 10,534,902 | 10,142,750 |
| 持作出售资产相关负债 | 0 | 0 | 0 | 0 | 0 |
| 26,865,415 | 16,265,507 | 11,485,492 | 10,534,902 | 10,142,750 | |
| 流动资产净值 | 111,854 | 8,932,254 | 12,327,826 | 23,866,186 | 11,722,421 |
| 资产总额减流动负债 | 38,775,472 | 48,668,953 | 44,721,237 | 57,813,438 | 43,328,437 |
非流动负债
| 2,316,667 | 9,924,343 | 13,612,165 | 16,310,585 | 4,517,072 |
资本及储备
| 股本 | 414,615 | 414,942 | 415,895 | 278,301 | 278,452 |
| 储备 | 29,574,680 | 29,799,213 | 24,159,728 | 31,235,692 | 29,645,662 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 股东资金 | 29,989,295 | 30,214,155 | 24,575,623 | 31,513,993 | 29,924,114 |
| 非控股权益 | 6,469,510 | 8,530,455 | 6,533,449 | 9,988,860 | 8,887,251 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 36,458,805 | 38,744,610 | 31,109,072 | 41,502,853 | 38,811,365 |
承担及或然负债
| 承担 | -- | -- | -- | -- | -- |
| 或然负债 | -- | -- | -- | -- | -- |
| 备注： | 实时报价更新时间为26/04/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 2,331,939 |
| 增长率 | -8.320% |
| 每股盈利/(亏损) | RMB 0.126 |
| 每股账面资产净值 (¥) | RMB 1.621 |